Kinoshita et al., 2011 - Google Patents
Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic β-cell function is preservedKinoshita et al., 2011
View PDF- Document ID
- 10621902213454560782
- Author
- Kinoshita Y
- Fujii H
- Takeshita A
- Taguchi M
- Miyakawa M
- Oyama K
- Yamada S
- Takeuchi Y
- Publication year
- Publication venue
- European journal of endocrinology
External Links
Snippet
Objective Impaired glucose metabolism is common in acromegaly, but it is not clear how glucose metabolism is impaired or what predicts its restoration after cure of the disease. To identify factors involved in the impairment of glucose metabolism in acromegaly, we …
- 206010000599 Acromegaly 0 title abstract description 62
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kinoshita et al. | Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic β-cell function is preserved | |
Martin et al. | Genetic evidence for different adiposity phenotypes and their opposing influences on ectopic fat and risk of cardiometabolic disease | |
Fieffe et al. | Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry | |
Lam et al. | Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community | |
Urbani et al. | Effects of medical therapies for acromegaly on glucose metabolism | |
Chakkera et al. | Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus | |
Melton III et al. | A bone structural basis for fracture risk in diabetes | |
Neggers et al. | Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients | |
Lastya et al. | The low level of glucagon-like peptide-1 (glp-1) is a risk factor of type 2 diabetes mellitus | |
Hofsø et al. | Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention | |
Hong et al. | Acromegaly and cardiovascular outcomes: a cohort study | |
Nolan et al. | Estimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes | |
Shim et al. | Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes | |
Yoshida et al. | Ketoacidosis as the initial clinical condition in nine patients with acromegaly: a review of 860 cases at a single institute | |
Yamazaki et al. | Effect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markers | |
Lv et al. | Identification of reactive hypoglycemia with different basic BMI and its causes by prolonged oral glucose tolerance test | |
Roy Chowdhury et al. | Diabetic retinopathy in newly diagnosed subjects with type 2 diabetes mellitus: contribution of β-cell function | |
Zhou et al. | Assessing 1-h plasma glucose and shape of the glucose curve during oral glucose tolerance test | |
Rasouli et al. | Association of baseline characteristics with insulin sensitivity and β-cell function in the glycemia reduction approaches in diabetes: a comparative effectiveness (GRADE) study cohort | |
Atquet et al. | Characteristics and treatment responsiveness of patients with acromegaly and a paradoxical GH increase to oral glucose load | |
Lindsay et al. | Rate of gestational weight gain and glucose-insulin metabolism among Hispanic pregnant women with overweight and obesity | |
Meyer et al. | Low IGF1 and high IGFBP1 predict diabetes onset in prediabetic patients | |
Wang et al. | Vaspin: A Novel Biomarker Linking Gluteofemoral Body Fat and Type 2 Diabetes Risk | |
Jeun et al. | Clinical outcomes of immune checkpoint inhibitor diabetes mellitus at a comprehensive cancer center | |
Rozing et al. | C-reactive protein and glucose regulation in familial longevity |